traditionally been considered to consist of two different forms, Crohn’s disease and ulcerative colitis. A genetic component was recognised for many years, with early studies prior to the year
assessed using Harvey Bradshaw index and Mayo score for Crohn???s Disease (CD) and Ulcerative Colitis (UC), respectively. The patients??? progress following diagnosis was also assessed. Result: 51 (1.4%) patients…
with a variety of gastrointestinal illnesses including diarrhea predominant irritable bowel syndrome (IBS-D), ulcerative colitis, Crohn’s disease, pouchitis, C. difficile colitis and chronic mesenteric ischemia. Its…
Ulcerative colitis (UC) and Crohn's infection (CD) are incendiary entrail illnesses (IBD) of hazy Etiology that cause considerable dreariness and incline to colorectal malignancy (CRC). There are two isoforms…
Graves’ disease (GD) and inflammatory bowel disease (IBD), particularly Crohn’s disease (CD) and ulcerative colitis (UC), has not been well documented. Therefore, this report reviews the literature regarding coexisting…
integrin-receptor antagonist indicated for the treatment of patients with moderately to severely active ulcerative colitis or Crohn's disease. We want to show our modest experience with ... tolerated. Vedolizumab may be…
class of disease-modifying therapy for inflammatory bowel diseases, including Crohn's disease and ulcerative colitis. The monoclonal anti-TNFα antibody Infliximab and Adalimumab are the current approved drugs…
studies (transversal and longitudinal), using peripheral blood mononuclear cells (PBMC) isolated from patients with ulcerative colitis and Crohn’s disease for the prediction of infl iximab effect
DHODH). It is currently in placebocontrolled phase 2 clinical testing in patients suffering from ulcerative colitis. Further clinical trials are planned in Crohn’s disease and Multiple Sclerosis. DHODH
colonize or damage tissues thus playing a role in the development of gastroenteritis and ulcerative colitis. The toxicity of H2 S to mammalian cells is comparable to that of cyanide
years old . There are two main tiers of IBD: Crohn’s disease and Ulcerative Colitis. The exact cause is still unknown, however genetics and the environment do play a role
gastrointestinal tract, oral cavity, and respiratory system. These conditions, such as Crohn’s disease, ulcerative colitis, celiac disease, and oral lichen planus, share a common feature the immune system ... agents…
elevated in inflamed intestinal tissue in inflammatory bowel disease (IBD), Crohn’s disease and ulcerative colitis. PLA2 hydrolyses the sn-2 fatty acyl bond of phospholipids (PL) liberating a fattyacid
reason for the lack of individualized therapies in ulcerative colitis (UC) may be that the conventional approaches are not adequate to understand the complexity of chronic inflammatory diseases. They mostly
suppress inflammation and relieve symptoms. Case 1: A 42-year-old woman with ulcerative colitis refractory to conventional treatment. She came to our clinic complaining of mucous, bloody stool
more evidences reveal intestinal microbiota to play an important role in IBD, especially in ulcerative colitis UC. Therapies via modulating gut microbiota have been introduced to IBD, including probiotics, prebiotics…
Introduction: Early-onset inflammatory bowel disease is a diagnosis of Crohn’s disease, ulcerative colitis and inflammatory bowel disease unclassified which runs a chronic, relapsing course, and can result
world population has latent TB infection. Patients with Crohn\\'s disease and Ulcerative Colitis that are treated with anti TNF-alfa agents, have a 14 times higher risk of reactivation
payers – comparable to estimates of other autoimmune diseases such as rheumatoid arthritis, psoriaisis, or ulcerative colitis. These estimates, moreover, likely understate the actual burden because they excluded…
local delivery of drug for the treatment of colonic diseases like inflammatory bowel disease (ulcerative colitis and crohn’s disease) and colon cancer, where it is necessary to attain high
Background & Aims: Ulcerative colitis (UC) and Crohn’s disease (CD) are inflammatory bowel diseases (IBD) of unclear etiology that cause substantial morbidity and predispose to colorectal-cancer (CRC). There
relapsing inflammatory conditions of the gastrointestinal tract and comprise Crohn’s disease (CD) and ulcerative colitis (UC). Both CD and UC are characterized by a great extent of heterogeneity
more effective control of inflammatory bowel disease (IBD) including Crohn’s disease and ulcerative colitis remain unmet need. In recent years, a new cell-mediated procedure induced by multi-potent
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.